日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Estimation of Dopamine D(1) Receptor Agonist Binding Kinetics Using Time-Resolved Functional Assays: Relation to Agonist-Induced Receptor Internalization by Investigational Antiparkinsonian Therapeutics.

利用时间分辨功能测定法估算多巴胺 D(1) 受体激动剂结合动力学:与研究性抗帕金森病疗法中激动剂诱导的受体内化的关系

Sahlholm Kristoffer, Svensson Peder, Malo Marcus, Andersson Daniel R, Betari Nibal

A nanoluciferase complementation-based assay for monitoring β-arrestin2 recruitment to the dopamine D(3) receptor.

一种基于纳米荧光素酶互补的检测方法,用于监测β-arrestin2募集到多巴胺D(3)受体

Burström Viktor, Xu Kuiying, Garro-Martínez Emilio, Mach Robert H, Sahlholm Kristoffer, Betari Nibal

In Vitro Comparison of Ulotaront (SEP-363856) and Ralmitaront (RO6889450): Two TAAR1 Agonist Candidate Antipsychotics

体外比较乌洛他隆(SEP-363856)和拉米他隆(RO6889450):两种TAAR1激动剂候选抗精神病药物

Ågren, Richard; Betari, Nibal; Saarinen, Marcus; Zeberg, Hugo; Svenningsson, Per; Sahlholm, Kristoffer

Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease

发现首个GSK-3β/HDAC双重抑制剂作为疾病修饰剂对抗阿尔茨海默病

De Simone, Angela; La Pietra, Valeria; Betari, Nibal; Petragnani, Nicola; Conte, Mariarosaria; Daniele, Simona; Pietrobono, Deborah; Martini, Claudia; Petralla, Sabrina; Casadei, Raffaella; Davani, Lara; Frabetti, Flavia; Russomanno, Pasquale; Novellino, Ettore; Montanari, Serena; Tumiatti, Vincenzo; Ballerini, Patrizia; Sarno, Federica; Nebbioso, Angela; Altucci, Lucia; Monti, Barbara; Andrisano, Vincenza; Milelli, Andrea